Literature DB >> 11189804

Patterns of prostate cancer treatment by clinical stage and age.

D Meltzer1, B Egleston, I Abdalla.   

Abstract

OBJECTIVES: This study analyzed prostate cancer treatment rates by age and clinical stage and contrasted these with rates by most accurate stage.
METHODS: We determined surgery and radiation rates by most accurate and clinical stage by using 1996 Surveillance, Epidemiology, and End Results data.
RESULTS: Treatment rates by clinical stage vs best stage differ significantly. For example, surgery rates for stages B, C, and D are 37%, 78%, and 13% by most accurate stage but 33%, 6%, and 1% by clinical stage. Treatment patterns by clinical stage vary substantially by age.
CONCLUSIONS: Treatment patterns should be described by clinical stage rather than most accurate stage, and they vary by age.

Entities:  

Mesh:

Year:  2001        PMID: 11189804      PMCID: PMC1446498          DOI: 10.2105/ajph.91.1.126

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  11 in total

1.  The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment.

Authors:  C J Mettlin; G P Murphy; M P Cunningham; H R Menck
Journal:  Cancer       Date:  1997-10-01       Impact factor: 6.860

2.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

Authors:  A W Partin; M W Kattan; E N Subong; P C Walsh; K J Wojno; J E Oesterling; P T Scardino; J D Pearson
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

3.  Recent trends in incidence and treatment of prostate cancer among elderly men.

Authors:  R K Severson; J E Montie; A T Porter; R Y Demers
Journal:  J Natl Cancer Inst       Date:  1995-04-05       Impact factor: 13.506

4.  An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team.

Authors:  G L Lu-Yao; D McLerran; J Wasson; J E Wennberg
Journal:  JAMA       Date:  1993-05-26       Impact factor: 56.272

5.  The National Cancer Data Base report on longitudinal observations on prostate cancer.

Authors:  C J Mettlin; G P Murphy; R Ho; H R Menck
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

6.  Geographic variation in the treatment of prostate cancer in Connecticut.

Authors:  A P Polednak
Journal:  Int J Technol Assess Health Care       Date:  1993       Impact factor: 2.188

7.  Trends and black/white differences in treatment for nonmetastatic prostate cancer.

Authors:  C N Klabunde; A L Potosky; L C Harlan; B S Kramer
Journal:  Med Care       Date:  1998-09       Impact factor: 2.983

8.  Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.

Authors:  L Harlan; O Brawley; F Pommerenke; P Wali; B Kramer
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

9.  The National Cancer Data Base report on prostate cancer.

Authors:  C J Mettlin; G Murphy
Journal:  Cancer       Date:  1994-09-01       Impact factor: 6.860

10.  Changes in prostate cancer incidence and treatment in USA.

Authors:  G L Lu-Yao; E R Greenberg
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321

View more
  12 in total

1.  Are Elderly Patients With Clinically Localized Prostate Cancer Overtreated? Exploring Heterogeneity in Survival Effects.

Authors:  Anirban Basu; John L Gore
Journal:  Med Care       Date:  2015-01       Impact factor: 2.983

2.  Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.

Authors:  Ryan K Berglund; Catherine M Tangen; Isaac J Powell; Bruce A Lowe; Gabriel P Haas; Peter R Carroll; Edith D Canby-Hagino; Ralph deVere White; George P Hemstreet; E David Crawford; Ian M Thompson; Eric A Klein
Journal:  Urology       Date:  2012-03       Impact factor: 2.649

3.  ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS.

Authors:  Anirban Basu
Journal:  J Appl Econ (Chichester Engl)       Date:  2014 June/July

4.  Racial Differences in Prostate Cancer Treatment: The Role of Socioeconomic Status.

Authors:  Megan Watson; David Grande; Archana Radhakrishnan; Nandita Mitra; Katelyn R Ward; Craig Evan Pollack
Journal:  Ethn Dis       Date:  2017-07-20       Impact factor: 1.847

5.  Locally advanced prostate cancer: a population-based study of treatment patterns.

Authors:  William T Lowrance; Elena B Elkin; David S Yee; Andrew Feifer; Behfar Ehdaie; Lindsay M Jacks; Coral L Atoria; Michael J Zelefsky; Howard I Scher; Peter T Scardino; James A Eastham
Journal:  BJU Int       Date:  2011-11-15       Impact factor: 5.588

6.  [Value of cystoprostatectomy in locally advanced prostate carcinoma].

Authors:  N Zantl; J E Gschwend
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

Review 7.  Background to and management of treatment-related bone loss in prostate cancer.

Authors:  Alfredo Berruti; Marcello Tucci; Carlo Terrone; Gabriella Gorzegno; Roberto M Scarpa; Alberto Angeli; Luigi Dogliotti
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 8.  Radical prostatectomy for the patient with locally advanced prostate cancer.

Authors:  John F Ward; Horst Zincke
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

9.  Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): ability to predict cancer progression and decision-making regarding adjuvant therapy after radical prostatectomy.

Authors:  Won Ik Seo; Pil Moon Kang; Dong Il Kang; Jang Ho Yoon; Wansuk Kim; Jae Il Chung
Journal:  J Korean Med Sci       Date:  2014-09-02       Impact factor: 2.153

10.  Prospective evaluation of vesicourethral anastomosis outcomes in robotic radical prostatectomy during early experience in a university hospital.

Authors:  Lucas Medeiros Burttet; Gabrielle Aguiar Varaschin; Andre Kives Berger; Leandro Totti Cavazzola; Milton Berger; Brasil Silva
Journal:  Int Braz J Urol       Date:  2017 Nov-Dec       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.